Ahmed KL, Turnbull B, Zhou L, et al. Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012–2016. Vaccine 2021 (published online Nov 20)
Anuforo B, McGee-Avila JK, Toler L, et al. Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey. BMC Public Health 2022 Jan 29;22(195)
Barnabas RV, Brown ER, Onono MA, et al. Efficacy of single-dose human papillomavirus vaccination among young African women. N Engl J Med Evidence 2022 (published online Apr 11)
Boakye EA, Stierwalt T, Grundy S, et al. Human papillomavirus vaccination uptake among Native Hawaiian and Pacific Islander adults in the United States. Annal Epidemiol 2021 (published online Sep 24)
Boender TS, Bartmeyer B, Coole L, et al. Risk of Guillain–Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020. Euro Surveill 2022 Jan 27;27(4)
Carnalla M, Torres-Ibarra L, Barrientos-Gutierrez T, et al. Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes. Vaccine 2021 (published online Jun 25)
Chen TYT, Chang R, Hung YM, et al. Association between human papillomavirus infection and sudden sensorineural hearing loss: a nationwide population-based cohort study. EClinicalMedicine 2022 (published online Apr 21)
Chido-Amajuoyi OG, Talluri R, Shete SS, et al. Safety concerns or adverse effects as the main reason for human papillomavirus vaccine refusal: National Immunization Survey–Teen, 2008 to 2019. JAMA Pediatr (Research letter) 2021 (published online Jun 28)
Denecke A, Iftner T, Iftner A, et al. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis. BMC Infect Dis 2021 (published online Jul 2)
Dickey BL, Giuliano AR, Sirak B, et al. Control of Epstein-Barr virus (EBV) in the oral cavity is associated with persistence of oral HPV 16/18 among men from the HPV Infection in Men (HIM) Study. J Infect Dis 2022 (published online Jun 9)
Drolet M, Laprise JF, Martin D, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis 2021 (published online Jul 7)
Hernandez-Lopez R, Hermosillo L, Leon-Maldonado L, et al. Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women. PLOS One 2021 (published online Jul 21)
Lee GY, Inthasorn P, Laowahutanont P, et al. Long-term effectiveness of human papillomavirus vaccines among adult women: a real-world scenario. Vaccine 2022 (published online Feb 18)
Lewis RM, Markowitz LE. Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017–March 2020. Vaccine 2022 (published online Apr 5)
Lin Y, Damgacioglu H, Suk R, et al. Trends in the incidence of human papillomavirus-associated cancers by county-level income and smoking prevalence in the United States, 2000-2018. JNCI Cancer Spectr 2022 Mar 3;6(2):pkac004
Madhivanan P, KruppK, Coudray M, et al. Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. cities. Vaccine 2021 Aug 9;39(34):4810-6
Martin-Merion E, Castillo-Cano B, Martin-Perez M, et al. Papillomavirus vaccination and Guillain-Barre syndrome among girls: a cohort study in Spain. Vaccine 2021 (published online Jun 24)
Munoz-Quiles C, Lopez-Lacort M, Diez-Domingo J, et al. Human papillomavirus vaccines effectiveness to prevent genital warts: a population-based study using health system integrated databases, 2009–2017. Vaccine 2021 (published online Dec 2)
Niyibizi J, Mayrand MH, Audibert F, et al. Association between human papillomavirus infection among pregnant women and preterm birth. JAMA Netw Open 2021 Sep 15;4(9):e2125308
Prabhu VS, Bansal N, Liu Z, et al. HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States. BMC Public Health 2021 Sep 6;21(1629)
Rebolj M, Cuschieri K, Mathews CS, et al. Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data. BMJ 2022 May 31;377:e068776
